Forecast: Antiinfective Medicine Sales in Mexico

In 2023, antiinfective medicine sales in Mexico stood at $1.18 billion. Between 2013 and 2023, the sector witnessed a fluctuating trend, initially experiencing a significant decline from $1.43 billion in 2013 to $1.12 billion in 2016, followed by a period of relative stability and modest growth. Over the last two years (2022-2023), the segment showed a positive year-on-year growth of 2.84% after a slight increase of 1.02% from 2021 to 2022. The five-year CAGR from 2019 to 2023 is -0.35%, highlighting a period of overall stagnation with minor annual variations.

[Future Trends]

Future forecasts suggest a gradual upward trend, with sales expected to reach $1.33 billion by 2028, reflecting a five-year CAGR of 1.91% and an overall growth rate of 9.93%. Factors influencing this trend may include advancements in pharmaceutical technology, demographic shifts, and healthcare policy changes.